C. elegans uses serotonin as a neurotransmitter to slow locomotion, and we have used this model system to discover that post-translational modifications appear to regulate serotonin signaling. Through large-scale genetic screens for mutants that fail to paralyze in response to exogenous serotonin, we found that C. elegans mutants for either of two subunits of the ELPC Elongator Protein Complex are defective for serotonin signaling. Conversely, transgenic animals overexpressing ELPC are hypersensitive to the effects of exogenous serotonin. ELPC is conserved from C. elegans to humans and functions as a cytoplasmic lysine acetylase to reversibly modify other proteins. This is the first time that ELPC or lysine acetylation has been implicated in regulating serotonin signaling. We used two-dimensional gel electrophoresis to show that in C. elegans lysates, Gao, a neural G protein encoded by the
goa-1 gene through which serotonin signals to slow locomotion, exists as a complex series of species of differing charge. Acetylation eliminates the positive charge on a lysine side chain, and differential acetylation on several Lys could produce the complex pattern of Gao species we see. Our preliminary results suggest that the series of differentially charged Gao species in wild-type lysates shifts to a less complex and more positively charged set of Gao species in lysates of ELPC mutants, as would be predicted if Gao is acetylated by ELPC. We isolated Gao from both mouse brain and C. elegans lysates and analyzed the purified proteins for post-translational modifications using mass spectrometry. In both species, Gao is acetylated on several conserved Lys residues near the N-terminus. We note that the signaling defects in ELPC mutants are much more restricted than those of Gao null mutants. Both ELPC and Gao mutants are defective for response to exogenous serotonin, but Gao null mutants have additional defects not seen in ELPC mutants, including defects in response to exogenous dopamine as well as in many behavioral assays. Thus we hypothesize that ELPC may reversibly acetylate Gao to specifically regulate its ability to be activated by serotonin receptors, while not strongly affecting its ability mediate signaling by other receptors. We are using CRISPR-Cas9 technology to mutate the acetylated Lys residues of Gao to the similar but non-acetylatable amino acid arginine to determine if acetylation at specific positions is responsible for regulating serotonin signaling.